Journal of Patient Safety & Quality Improvement

Journal of Patient Safety & Quality Improvement

Is Phaeohyphomycosis an Emerging Fungal Infection in Iran? A Short Communication

Document Type : Short Communication

Authors
Hossein Zarrinfar 1
Chhavi Bathla 2
1 Allergy Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
2 Facilitator-CPRL Course, Bharat Rural Livelihoods Foundation, New Delhi, India.
10.22038/psj.2020.46271.1262
Abstract
Introduction:
Phaeohyphomycosis is a rare opportunistic fungal infection that can be caused by dematiaceous fungi. The clinical manifestations of this disease are highly diverse and include cutaneous, subcutaneous, and systemic forms. However, the mortality rate of this infection depends on the immune status of patients. Although infections caused by black fungi have been on an increasing trend during the past decade, infections with dematiaceous fungi have rarely been reported in the Middle East. However, some fungal species are associated with a disseminated disease without the known clinical and pathologic risk factors. The analysis of DNA sequence is a highly effective method for differentiating various species among some genera, due to the variable cultural and morphological characteristics of DNA. Despite the presence of therapeutic methods, there are numerous reports regarding the high mortality rate of this infection. Published studies indicate no specific risk factors for phaeohyphomycosis and report the incidence of this disease in immunocompetent individuals. Moreover, selective treatment for these rare infections has not even been defined in clinical studies. However, the clinical syndromes associated with dematiaceous fungi should be considered in the Middle East, Iran.
Keywords
Fungus
Phaeohyphomycosis
The Middle East
Iran
Subjects
  1. Revankar SG, Patterson JE, Sutton DA, Pullen R, Rinaldi MG. Disseminated phaeohyphomycosis: review of an emerging mycosis. Clinical Infectious Diseases. 2002; 34(4): 467-76.
  2. Saunte DM, Tarazooie B, Arendrup MC, de Hoog GS. Black yeast-like fungi in skin and nail: it probably matters. Mycoses. 2012 Mar; 55(2): 161-7. PubMed PMID: 21736629.
  3. Najafzadeh MJ, Sutton DA, Keisari MS, Zarrinfar H, de Hoog GS, Chowdhary A, et al. In vitro activities of eight antifungal drugs against 104 environmental and clinical isolates of Aureobasidium pullulans. Antimicrobial agents and chemotherapy. 2014 Sep;58(9):5629-31. PubMed PMID: 25001309. Pubmed Central PMCID: 4135826.
  4. Feng P, Klaassen CH, Meis JF, Najafzadeh M, Van Den Ende AG, Xi L, et al. Identification and typing of isolates of Cyphellophora and relatives by use of amplified fragment length polymorphism and rolling circle amplification. Journal of clinical microbiology.2013;51(3):
    931-7.
  5. Lian X, De Hoog G. Indoor wet cells harbour melanized agents of cutaneous infection. Medical mycology. 2010;48(4):622-8.
  6. Bakhshizadeh M, Hashemian HR, Najafzadeh MJ, Dolatabadi S, Zarrinfar H. First report of rhinosinusitis caused by Neoscytalidium dimidiatum in Iran. Journal of medical microbiology. 2014;63(7):1017-9.
  7. Najafzadeh M, Fata A, Naseri A, Keisari MS, Farahyar S, Ganjbakhsh M, et al. Implantation phaeohyphomycosis caused by a non-sporulating Chaetomium species. Journal de mycologie medicale. 2014;24(2):161-5.
  8. Didehdar M, Gokanian A, Sofian M, Mohammadi S, Mohammadi R, Aslani N, et al. First fatal cerebral phaeohyphomycosis due to Rhinocladiella mackenziei in Iran, based on ITS rDNA. Journal de Mycologie Medicale. 2015; 25(1): 81-6.
  9. Geramishoar M, Zomorodian K, Zaini F, Saadat F, Tarazooie B, Norouzi M, et al. First case of cerebral phaeohyphomycosis caused by Nattrassia mangiferae in Iran. Jpn J Infect Dis. 2004; 57(6):285-6.

10. Vaezi A, Mardani M, Fakhim H, Yaghoobi MH, Abtahian Z, Nasri E, et al. Severe disseminated phaeohyphomycosis in a patient with inherited CARD9 deficiency. Archives of Clinical Infectious Diseases. 2018 (In Press).

11. Falahati M, Ghasemi Z, Zaini F, Farahyar S, Javad M, Najafzadeh MA, et al. The first case of Onychomycosis due to Exophiala dermatitidis in Iran: Molecular identification and Antifungal Susceptibility. Bull Env Pharmacol Life Sci. 2014; 3(5):125-9.

12. Mirhendi H, Fatemi MJ, Bateni H, Hajabdolbaghi M, Geramishoar M, Ahmadi B, et al. First case of disseminated phaeohyphomycosis in an immunocompetent individual due to Alternaria malorum. Medical mycology. 2013;51(2):
196-202.

13. Mohammadi R, Mohammadi A, Ashtari F, Khorvash F, Hakamifard A, Vaezi A, et al. Cerebral phaeohyphomycosis due to Rhinocladiella mackenziei in Persian Gulf region: A case and review. Mycoses. 2018;61(4):261-5.

14. Basiri Jahromi S, Khaksar A, Iravani K. Phaeohyphomycosis of the sinuses and chest by cladosporium bantianum. Medical Journal of The Islamic Republic of Iran (MJIRI). 2002;16(1):          55-8.

15.Binesh F, Ayatollahi J, Behniafard N, Moghimi M, Vajihinejad M. Phaeohyphomycosis in an Immunocompetent Host: Case Report and Literature Review.

16. Gomes RR, Vicente VA, de Azevedo CM, Salgado CG, da Silva MB, Queiroz-Telles F, et al. Molecular epidemiology of agents of human chromoblastomycosis in Brazil with the description of two novel species. PLoS neglected tropical diseases. 2016;10(11):e0005102.

17. Bittencourt AL, Machado PR, Araujo Mg. Subcutaneous phaeohyphomycosis caused by Cyphellophora pluriseptata. European Journal of Dermatology. 2002;12(1):103-6.

Journal of Patient Safety & Quality Improvement
Volume 8, Issue 2
Spring 2020
Pages 123-126